Atlas Trials

Empagliflozin in Adolescent Diabetes

Clinical trial NCT04917692 · WITHDRAWN

Trial details

NCT number
NCT04917692
Sponsor
Ohio State University
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
type1diabetes
Start date
2021-07-01
Primary completion
2022-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.